Stryker’s ASC Advantage Is Real But Largely Priced In (NYSE:SYK)

Group 1 - Stryker Corporation launched its ambulatory surgery center (ASC) business in 2020 to address the demand for migrating certain procedural services [1] - The ASC business is not merely aimed at growth through product sales but is a strategic response to market needs [1] Group 2 - Mr. Arunangshu Das is developing Tranzoro Investments to bridge the gap between US and Indian investors [1] - The focus will be on providing insights into liquid and well-known India-focused ETFs and ADRs for US investors, while covering a wide range of US equities, ETFs, and REITs for Indian investors [1] - Mr. Das emphasizes an income and growth-focused investment strategy [1]